• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

精神分裂症门诊患者的治疗依从性与睡眠质量。

Treatment adherence and quality of sleep in schizophrenia outpatients.

机构信息

Lisbon's Psychiatric Hospitalar Center , Lisbon , Portugal.

出版信息

Int J Psychiatry Clin Pract. 2014 Jan;18(1):70-6. doi: 10.3109/13651501.2013.845219. Epub 2013 Oct 28.

DOI:10.3109/13651501.2013.845219
PMID:24047426
Abstract

OBJECTIVE

Patients with schizophrenia (SZ) often present sleep complaints, and patients with sleep disturbances are at a greater risk for symptom worsening after antipsychotic discontinuation. Long-term adherence to antipsychotic treatment remains a challenge for clinicians, and the relationship between quality of sleep and treatment adherence in SZ outpatients has been poorly studied.

METHODS

In this cross-sectional, non-interventional study, 811 adult outpatients with a diagnosis of SZ were divided into two groups according to the presence (or absence) of sleep disturbances, and assessed using measures of symptom severity, quality and patterns of sleep, adherence/compliance to treatment, and family support degree.

RESULTS

Patients with sleep disturbances were significantly more symptomatic (p < 0.0001), and scored significantly higher on the Pittsburgh Sleep Quality Index (PSQI) as compared with patients without sleep disturbances (p < 0.0001). More compliant patients showed less sleep disturbances (p < 0.0001); moreover, patients with worse compliance to pharmacological treatment showed significantly higher scores on the PSQI (p < 0.0001). Regarding family support degree, patients with sleep disorders presented a lower family support (p = 0.0236), and patients with worse treatment adherence had worse family support (p < 0.0001).

CONCLUSIONS

Our findings show that SZ outpatients reporting sleep disturbances show greater symptom severity, and worse adherence/compliance to treatment, as well as a lower family support.

摘要

目的

精神分裂症(SZ)患者常出现睡眠问题,且睡眠障碍患者在抗精神病药物停药后症状恶化的风险更高。长期坚持抗精神病药物治疗仍然是临床医生面临的挑战,SZ 门诊患者的睡眠质量与治疗依从性之间的关系尚未得到充分研究。

方法

在这项横断面、非干预性研究中,根据是否存在睡眠障碍,将 811 名成年 SZ 门诊患者分为两组,并使用症状严重程度、睡眠质量和模式、治疗依从性/遵医嘱性以及家庭支持程度的评估措施进行评估。

结果

与无睡眠障碍的患者相比,有睡眠障碍的患者症状更严重(p < 0.0001),匹兹堡睡眠质量指数(PSQI)评分也显著更高(p < 0.0001)。依从性更高的患者睡眠障碍更少(p < 0.0001);此外,对药物治疗依从性较差的患者 PSQI 评分显著更高(p < 0.0001)。关于家庭支持程度,睡眠障碍患者的家庭支持较低(p = 0.0236),而治疗依从性较差的患者家庭支持更差(p < 0.0001)。

结论

我们的研究结果表明,报告睡眠障碍的 SZ 门诊患者表现出更严重的症状、治疗依从性/遵医嘱性更差,以及家庭支持更低。

相似文献

1
Treatment adherence and quality of sleep in schizophrenia outpatients.精神分裂症门诊患者的治疗依从性与睡眠质量。
Int J Psychiatry Clin Pract. 2014 Jan;18(1):70-6. doi: 10.3109/13651501.2013.845219. Epub 2013 Oct 28.
2
[Therapeutic alliance, a stake in schizophrenia].[治疗联盟,精神分裂症中的一个利害关系因素]
Encephale. 2009 Feb;35(1):80-9. doi: 10.1016/j.encep.2007.12.009. Epub 2008 May 19.
3
Medication adherence in schizophrenia: a comparison between outpatients and relapse cases.精神分裂症患者的药物依从性:门诊患者与复发患者的比较
East Asian Arch Psychiatry. 2014 Jun;24(2):68-74.
4
[Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].[使用长效注射用利培酮的基本原理:法国精神科医生的一项调查]
Encephale. 2013 May;39 Suppl 1:S8-14. doi: 10.1016/j.encep.2012.03.005. Epub 2013 Mar 28.
5
Adherence to Antipsychotic Medication by Community-Based Patients With Schizophrenia in China: A Cross-Sectional Study.中国社区精神分裂症患者抗精神病药物治疗依从性的横断面研究
Psychiatr Serv. 2016 Apr 1;67(4):431-7. doi: 10.1176/appi.ps.201500056. Epub 2016 Jan 4.
6
Symptom severity and attitudes toward medication: impacts on adherence in outpatients with schizophrenia.症状严重程度和对药物的态度:对精神分裂症门诊患者依从性的影响。
Schizophr Res. 2012 Feb;134(2-3):226-31. doi: 10.1016/j.schres.2011.11.008. Epub 2011 Nov 30.
7
Control beliefs, therapeutic relationship, and adherence in schizophrenia outpatients: a cross-sectional study.精神分裂症门诊患者的控制信念、治疗关系与依从性:一项横断面研究。
Am J Health Behav. 2014 Nov;38(6):914-23. doi: 10.5993/AJHB.38.6.13.
8
Schizophrenia patients with predominantly positive symptoms have more disturbed sleep-wake cycles measured by actigraphy.经测谱仪测量,以阳性症状为主的精神分裂症患者睡眠-觉醒周期更为紊乱。
Psychiatry Res. 2011 Aug 30;189(1):62-6. doi: 10.1016/j.psychres.2010.12.031. Epub 2011 Jan 22.
9
[Relationships between insight and medication adherence in subjects with psychosis].[精神病患者领悟与药物依从性之间的关系]
Encephale. 2003 Sep-Oct;29(5):430-7.
10
Relationships between insight and medication adherence in outpatients with schizophrenia and bipolar disorder: prospective study.精神分裂症和双相情感障碍门诊患者领悟与药物依从性之间的关系:前瞻性研究
Psychiatry Clin Neurosci. 2005 Aug;59(4):403-9. doi: 10.1111/j.1440-1819.2005.01392.x.

引用本文的文献

1
Sleep duration and its associated factors in schizophrenia patients: a large-scale cross-sectional survey.精神分裂症患者的睡眠时间及其相关因素:一项大规模横断面调查。
BMC Psychiatry. 2025 Feb 13;25(1):123. doi: 10.1186/s12888-025-06581-1.
2
Longitudinal evolution of the transdiagnostic prodrome to severe mental disorders: a dynamic temporal network analysis informed by natural language processing and electronic health records.严重精神障碍的跨诊断前驱期的纵向演变:基于自然语言处理和电子健康记录的动态时间网络分析
Mol Psychiatry. 2025 Jan 22. doi: 10.1038/s41380-025-02896-3.
3
Biomarker discovery using machine learning in the psychosis spectrum.
在精神病谱系中使用机器学习进行生物标志物发现。
Biomark Neuropsychiatry. 2024 Dec;11. doi: 10.1016/j.bionps.2024.100107. Epub 2024 Aug 26.
4
Treatment adherence: A Concept Analysis Using the Walker & Avant Method.治疗依从性:运用沃克与阿凡特方法的概念分析
Patient Prefer Adherence. 2024 Oct 1;18:2067-2075. doi: 10.2147/PPA.S477615. eCollection 2024.
5
Cognitive behavioural therapy for insomnia (CBT-I) in schizophrenia and schizoaffective disorder: protocol for a randomised controlled trial.失眠的认知行为疗法(CBT-I)在精神分裂症和分裂情感障碍中的应用:一项随机对照试验的方案。
BMJ Open. 2024 Jun 12;14(6):e076129. doi: 10.1136/bmjopen-2023-076129.
6
Targeted metabolomics-based understanding of the sleep disturbances in drug-naïve patients with schizophrenia.基于靶向代谢组学的药物初治精神分裂症患者睡眠障碍的认识。
BMC Psychiatry. 2024 May 13;24(1):355. doi: 10.1186/s12888-024-05805-0.
7
Light-Dark and Activity Rhythm Therapy (L-DART) to Improve Sleep in People with Schizophrenia Spectrum Disorders: A Single-Group Mixed Methods Study of Feasibility, Acceptability and Adherence.明暗与活动节律疗法(L-DART)改善精神分裂症谱系障碍患者的睡眠:一项关于可行性、可接受性和依从性的单组混合方法研究
Clocks Sleep. 2023 Dec 4;5(4):734-754. doi: 10.3390/clockssleep5040048.
8
Digital Phenotyping in Adults with Schizophrenia: A Narrative Review.精神分裂症成人的数字化表型:叙事综述。
Curr Psychiatry Rep. 2023 Nov;25(11):699-706. doi: 10.1007/s11920-023-01467-z. Epub 2023 Oct 20.
9
Assessing the psychometric properties of the PROMIS sleep measures in persons with psychosis.评估精神病患者中 PROMIS 睡眠测量的心理计量学特性。
Sleep. 2021 Nov 12;44(11). doi: 10.1093/sleep/zsab140.
10
Rehospitalization Risk of Receptor-Affinity Profile in Antipsychotic Drug Treatment: A Propensity Score Matching Analysis Using a Japanese Employment-Based Health Insurance Database.抗精神病药物治疗中受体亲和力谱与再住院风险:一项基于日本就业型健康保险数据库的倾向得分匹配分析
Neuropsychiatr Dis Treat. 2020 Nov 30;16:2871-2879. doi: 10.2147/NDT.S276030. eCollection 2020.